Bora CDMO Bora CDMO

X

Find Atamestane manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Atamestane
Also known as: 96301-34-7, Atamestane [inn], 1-methylandrosta-1,4-diene-3,17-dione, Sh-489, 62ga3k28b6, Atamestanum [latin]
Molecular Formula
C20H26O2
Molecular Weight
298.4  g/mol
InChI Key
PEPMWUSGRKINHX-TXTPUJOMSA-N
FDA UNII
62GA3K28B6

Atamestane is a synthetic steroidal substance with antineoplastic activity. Atamestane binds irreversibly to and inhibits the enzyme aromatase, thereby blocking the conversion of cholesterol to pregnenolone and the peripheral aromatization of androgenic precursors into estrogens. (NCI04)
1 2D Structure

Atamestane

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(8R,9S,10S,13S,14S)-1,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-dione
2.1.2 InChI
InChI=1S/C20H26O2/c1-12-10-14(21)11-13-4-5-15-16-6-7-18(22)19(16,2)9-8-17(15)20(12,13)3/h10-11,15-17H,4-9H2,1-3H3/t15-,16-,17-,19-,20-/m0/s1
2.1.3 InChI Key
PEPMWUSGRKINHX-TXTPUJOMSA-N
2.1.4 Canonical SMILES
CC1=CC(=O)C=C2C1(C3CCC4(C(C3CC2)CCC4=O)C)C
2.1.5 Isomeric SMILES
CC1=CC(=O)C=C2[C@]1([C@H]3CC[C@]4([C@H]([C@@H]3CC2)CCC4=O)C)C
2.2 Other Identifiers
2.2.1 UNII
62GA3K28B6
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 1-methyl-1,4-androstadiene-3,17-dione

2. Sh 489

3. Sh-489

4. Sh489

2.3.2 Depositor-Supplied Synonyms

1. 96301-34-7

2. Atamestane [inn]

3. 1-methylandrosta-1,4-diene-3,17-dione

4. Sh-489

5. 62ga3k28b6

6. Atamestanum [latin]

7. Atamestano [spanish]

8. Atamestano

9. Atamestanum

10. (8r,9s,10s,13s,14s)-1,10,13-trimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-3h-cyclopenta[a]phenanthrene-3,17(6h)-dione

11. Ccris 6528

12. Unii-62ga3k28b6

13. Biomed-777

14. 1-methyl-1,4-androstadiene-3,17-dione

15. Androsta-1,4-diene-3,17-dione, 1-methyl-

16. Atamestane [who-dd]

17. Schembl59128

18. Chembl2105987

19. Dtxsid30869268

20. Zinc4214890

21. Db12194

22. (8r,9s,10s,13s,14s)-1,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-3,17-dione

23. 1-methyl-androsta-1,4-diene-3,17-dione

24. 1-methyl-androsta-1,4 -diene-3,17-dione

25. Q4812727

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 298.4 g/mol
Molecular Formula C20H26O2
XLogP32.9
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count0
Exact Mass298.193280068 g/mol
Monoisotopic Mass298.193280068 g/mol
Topological Polar Surface Area34.1 Ų
Heavy Atom Count22
Formal Charge0
Complexity626
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY